Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Top Stories

Posted By Wanda Rich

Posted on April 6, 2022

British drugmaker GSK stops supplement, vitamin sales to Russia

(Reuters) -GlaxoSmithKline said on Wednesday its consumer arm has stopped shipments of supplements and vitamins to Russia as a result of Moscow’s invasion of Ukraine and would prioritise the supply of over-the-counter medicines for basic needs.

The British drugmaker has also reiterated that it would keep supplying essential medicines and vaccines to Russia. GSK has however, halted clinical trials in the country and stopped as much direct involvement with Russia as possible.

As the West has tightened restrictions on Moscow over its invasion of Ukraine, which the Kremlin calls “a special military operation”, healthcare companies have continued to supply medicines to Russia as these are excluded from sanctions on humanitarian grounds.

GSK has said that where it faces challenges in delivering medicines it would prioritise the supply of essentials, while its consumer business, in which Pfizer has a 32% stake, would also reduce the supply of oral health products.

“We support global sanctions and will comply with them,” GSK said on its website. “We have taken a precautionary approach to stop, to the fullest extent possible, any direct involvement and support to the Russian government and military.”

Drugmakers typically have contracts with governments and their armed forces for public and internal supplies.

GSK is also in talks with the World Health Organization, the European Union and UNICEF for the supply of essential vaccines for children to Poland to support a fast growing refugee population there.

GSK, the world’s biggest vaccine maker by sales, produces several major childhood vaccines, including against polio.

Last month, EU health commissioner Stella Kyriakides said the bloc was planning to buy and distribute vaccines against measles, polio, tuberculosis and COVID-19 to immunize Ukrainian children and other unvaccinated refugees.

More than 3.5 million people have fled the war in Ukraine, United Nations data showed in March. Neighbouring Poland was home to the biggest Ukrainian diaspora in the region even before the war.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shounak Dasgupta and Alexander Smith)

Recommended for you

  • From Fossil Fuels to Green Energy: Economic Implications of the Global Energy Transition

  • Nan Shan Continues Its Commitment to Sustainability

  • Unpacking Economic Growth Why These Factors Matter More Than Ever